Biogenesis of the yeast vacuole (lysosome) Active site mutation in the vacuolar aspartate proteinase yscA blocks maturation of vacuolar proteinases  by Rupp, Steffen et al.
Volume 293, number 1,2, 62-66 FEBS 10386 
0 1991 Federation of European Biochemical Societies 00145793/91/$3.50 
November 1991 
Biogenesis of the yeast vacuole (lysosome) 
Active site mutation in the vacuolar aspartate proteinase yscA blocks maturation 
of vacuolar proteinases 
Steffen Rupp’, Hans H. Hirsch’ and Dieter H. Wolf’ 
‘Institut fir Biochemie der Utliversirdt Stuttgart, Pfaffenwaldrbrg 55, O-7000 Sturtgart 80, Germany and ‘Instilut fiir 
Medizinische Mikrobiologie, Universitiit Basel, Pctersplurz 10, CH-4003 Bascl, Switzer arrd 
Received 24 September 199 1 
The activation process of vacuolar (lysosomal) proteinases in the yeast Succlrarcmyces cerceisiue is initiated by the PRA/ (PEP4) gene product. 
proteinase yscA. To elucidate the activation process of proteinase yscA the catalytically active amino acid AspmJ of the enzyme was exchanged 
with Ala”” using site directed mutagenesis. The resulting: proteinase yscA-Ala”” showed no proteolytic activity against the substrate hemoglobin. 
The mutant protein did not undergo processing in vivo. This phenomenon is in good agreemcnt with the hypothesis that maturation of proteinase 
yscA is due to self-processing of pro-proteinase yscA. Furthermore. proteinase yscA-Alaw is not able to convert the zymogens pro-proteinase yscB 
and pro-carboxypeptidase yscY to the mature enzymes. 
Proteolysis: Aspartate proteinase: Active site mutant: Yeast: Socchnrorqws cerevisioc 
1. INTRODUCTION 
The yeast vacuole, the Iysosome-like organelle of this 
organism, contains a multitude of proteolytic enzymes. 
A functional vacuolar proteolytic system in Succl~o- 
rrzyces cerevisiae is essential for cell survival under nu- 
trient deprivation and the differentation process of spo- 
rulation [l]. The vacuolar proteinases yscA (PrA) and 
yscB (PrB) not only have an important function in pro- 
tein degradation but also play a crucial role in specific 
proteolytic processing and enzyme precursor activation 
events. The soluble PrA. PrB and carboxypeptidase 
yscY (CpY) are synthesized as precursors of higher mo- 
lecular weight. Maturation occurs in the vacuole or a 
post-Golgi pre-vacuolar compartment : Y proteoiytic 
cleavage of the respective pro-peptide segments (for re- 
views see [2-51). 
PrA occupies a key position in these activation 
events. A mutation @ep4-3) in the structural gene of 
PrA has been described which leads to the accumulation 
of pro-PrB and pro-CpY in the vacuole [G]. PrA is ho- 
mologous to other aspartyl proteinases. Mature PrA 
shows 40% amino acid identity with human pepsin and 
Ahhtwirrriorw ER. endoplasmatic reticulum: CpY, carboxypcptidasc 
yscY; PrA, protcinasc yscA; PrB, protcinasc yscB. 
Corrcspotrk~rcc ~rklress: D.H. Wolf, Institut fUr Biochcmic. Univcr- 
sit& Stuttgart, Phffcnwaldrih8 55. 7000 Stuttgart NO. Germany. fax: 
(49) (71 I) 685 4392. 
46% identity with the lysosomal human cathepsin D. 
PrA is synthesized as a pre-pro-enzyme of 44 kDa [7.8]. 
The signal sequence is cleaved off after transfer into the 
ER by signal peptidase between amino acids 22 and 23 
[9] as predicted by the rules of von Heinje [lo]. During 
transit through the ER two N-linked core oligosacchari- 
des are added to pro-PrA, which are trimmed and exten- 
ded in the Golgi complex resulting in a molecular weight 
of 52 kDa for the pro-enzyme [i I]. During or upon 
delivery to the vacuole the pro-peptide is cleaved off. 
Pro-PrA is processed in two steps: in a first step the 52 
kDa precursor is transferred into a 43 kDa form which 
is further processed to the mature 42 kDa protein. The 
first processing step is thought to be autocatalytic in 
nature, whereas the second step is dependent on PrB 
activity (H.H. Hirsch, H. Schiffer and H. Mtiller. in 
preparation). Amino acid 77 of pre-pro-PrA constitutes 
the amino terminus of the mature enzyme [12]. The 
pro-peptide fragment of PrA is able to direct the enzyme 
invertase into the vacuole and thus contains vacuolar 
targeting information [9]. 
In an analogy to pepsin an autocatalytic activation 
caused by an acidic environment had been suggested for 
PrA [7,8]. Recent experiments, however, using yeast 
strains completely lacking a subunit of the vacuolar 
ATPase (VA T2 or VMA.? gene product), resulted in a 
neutral vacuolar environment and showed the mature 
active forms of PrA and CpY [13,14]. To elucidate the 
activation process of pro-PrA WC introduced a mutation 
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into the enzyme at amino acid 294 (prul-AlaZY4) which 
is predicted CO be one of the catalytically active amino 
acid residues. The outcome of this mutation on PrA 
maturation and on the maturation events of other va- 
cuolar enzymes was studied. 
2. MATERIALS AND METHODS 
2.1. Chemiculs 
All enzymes used in DNA manipulation were obtained from Boeh- 
ringer-Mannheim (Germany), Bethesda Research Laboratories 
(Basel, Switzerland) or Pharmacia (Freiburg, Germany). Dideoxyse- 
quencing [IS] was carried out according to the instructions of the T7 
polymerase sequencing kit (Pharmacia, Freiburg, Germany). Purified 
PrA was purchased from Sigma (Deisenhofen, Germany). Pepstatin, 
chymostatin and zymolyase 100 000 were obtained from the Peptide 
Institute (Osaka, Japan). [‘SS]methionine and [cw-35S]-labeled dATP 
were obtained from Amersham (Braunschwcig, Germany). All other 
chemicals were obtained from Roth (Karlsruhe, Germany), Pharma- 
cia (Freiburg, Germany) or Merck (Darmstadt, Germany). The PRAI 
gene was provided by Dr A. Hinnen (Base]. Switzerland). 
2.2. Medio 
E. colt’ strains were grown in LB Medium [16] with or without 
ampicillin (50 &ml). The following yeast growth media were used: 
Y PD medium (2% glucose, 1% yeast extract and 2% peptone) and MV 
medium (2% glucose, 0.67% yeast nitrogen base without amino acids 
and sl;pplemer,ts required by auxotrophic strains). [‘5S]methionine 
labeling medium was used as described in [I I]. 
2.3. E. coli and yeast srrainr 
E. co/i strains: JM 109 {reAl, endoAI, gyrA96, tht-, hsdRI7, srrpE44, 
relA1 (luc. pro) F ‘lraD36, proA& Ia@, IacZ, AMIS} [17], RZ 1032 
(duur-, to@) and BMH 71-18 {d(lac-proAB) thisup- 
E[F’proAB(lacIqZdMl S)]} were used [18]. Yeast strains: YSIS 
(MATu, llis3-11.15, Ieut-3.112, uru3A5, canR) [l9], YHH6S (MAT& 
pralAEN::HISjl, his3-11.15, IeuZ-3,112, ura3A5, canR) (H.H. Hirsch, 
unpublished), SRI (MAT& pralAEN::HISS, his3-II.IS. leu2-3,112, 
uru3A5, canR, pDP83pral-AlfW) and SR2 (MAT& pralAEN::HIS3, 
his3-11,15. /eu2-3,112, ura3A5. can’ pDP83PRAl). 
2.4. Moleculur biological techniques and plasmids 
Purification, restriction, ligation, analysis of DNA and transforma- 
tion of E. co/i and S. cerevisiae were carried out according to standard 
procedures [16,201. Introduction of the I .9 kbp Sacl/X/lol PRA I and 
pral-Afa’w alleles into yeast was performed in the vector pDP83 
(GENII. ARSI, URA3, ampR. IacZ) (D. Pridmore, unpublished). 
Bluescript KS’ M 13 (Stratagene) was used for mutagenesis and dide- 
oxyscquencing. For in vitro transcription the PRAI and pral-A/(? 
genes were subcloned as I .S kbp EcoRIIXlloI fragments into the vector 
pGEM2 (Promega Biotec). 
2.5. Sire directed trturagertesis and DNA-scqucncing 
Site directed mutagenesis replacing amino acid Asp at position 294 
of the PrA sequence with Ala was carried out as described by Kunkel 
[ 181 using the mutagenic IR-mer 5’-GCCATCGCGACTGGTACT-3’. 
The plasmid Bluescript Ml3 KS’, containing a 642 bp EcoRVIXlroI 
fragment of the PRAl gene in the respective polylinkcr restriction 
sites. was used for sitedircctcd mutagenesis. Single stranded DNA was 
prepared in L, co/i RZ 1032 using the helper virus R408 (Stratagcnc, 
San Diego, USA) (211. The mutated pral-A/d” gcnc fragment was 
subcloncd into the PRAI wild-type gene and the nucleotide scqucnce 
of both strands over the cntirc open reading frame of the resulting 
prul-A/n”’ gcnc was confirmed by the didcoxyshain terminating 
method [IS] using T7 polymerase and [&‘S)-labclcd dATP. 
2.6. A vitro rrutt.rc.ril~lintr-tnrttskrriott 
For in vitro transcription of the PRAl and prai-Alu-9’ gcr1cs 
pGEM2PRAI and pGEMZpraI-A@’ were linearized downstream of 
the open reading frame by digestion with PsrI. SP6 polymerase direc- 
ted transcriptions, wheat germ extract mediated translation and SDS- 
PAGE of the radiolabeled proteins was performed as described in [22]. 
2.7. Pulse-chase experiments 
Labeling of cells, preparation of cell extracts, immunoprccipitation 
of proteins, SDS-PAGE and fluorography were done as outlined by 
Mechler et al. [I 1,231. Previously characterized antisera against PrA, 
PrB and CpY l1ave been used [ 11.231. 
2.8. En:_v?tie assays 
PrA was tested against acid hemoglobin as substrate as described 
by Saheki and Holzer 1241. a-Mannosidase was tested with a-nitroahe- 
n&a-D-mannopyran&ide as described by Van der Wild& et-all i25]. 
NADPH cytochrome c oxidase was assayed as described by Kubota 
[26] and glucose&phosphate dehydrogcnase was measured as de- 
scribed by Deutsch [27]. The amount of protein was determined by the 
method of Lowry ct al. [28]. 
2.9. Isolation of vacuoles 
Cells were grown for I8 h at 30°C in YPD medium. Sphcroplast 
formation, lysis of spheroplasts with DEAE-dextran and purification 
were performed as described by Wiemken et al. [29] with the modifica- 
tions outlined by Mechler et al. [30]. SDS-PAGE and electro-immuno- 
blotting were done as described in [30]. The enrichment of a marker 
enzyme of the vacuolar membrane, a-mannosidase could be determi- 
ned :o be ‘I-fold for strain SRI and 15-fold for strain YHH65 while 
the activity of NADPH cytochrome c oxidase, an ER-marker enzyme, 
was reduced 4.fold for both vacuolar preparations. Glucose-6-phos- 
phate dehydrogenase activity, a cytosolic marker enzyme, was not 
detectable in either of the vacuolar fractions. 
3. RESULTS 
3.1. Introduction of the mutation pral-Ala294 into Ihe 
PRAI gene 
Among aspartate proteinases the amino acid sequen- 
ces containing the catalytic aspartate residues are con- 
served. The two putative catalytic aspartates of protei- 
nase yscA are located at position 109 and 294 of the 
peptide sequence. Using site directed mutagenesis 
Asp294 was changed to Ala294 [31]. Sequencing data of 
both strands of the entire open reading frame confirmed 
the exchange of Asp294 to A1a294 as described in section 
2.5. (not shown). 
3.2. The mutation pral-Ala294 prevents maturation of 
pro-PrA-.41a2” 
Analysis of cellular and vacuolar extracts of strain 
SRl (praIAEN::HIS3, pDP83prui-AIa2g4) showed no 
proteolytic activity against hemoglobin, a roirtinely 
used PrA substrate. 
To follow processing of the PrA-Ala294 mutant pro- 
tein, cells of strain SR 1 (praIAEN::HIS3, pDP&~pral- 
,4k.1~~~), and for control, cells of strains YS18 (PRAI) 
and YHH65 (prufAEN::HIs3) were labeled with 
[“Slmethionine for 30 min and chased for 2 h with 
non-radioactive methionine [11,23]. In contrast to wild- 
type YSl8 (Fig. 1, lanes 1 and 2) no processing of the 
mutant pro-PrA-Alaz94 to the mature enzyme was ob- 
served (Fig. 1, lanes 3 and 4). In addition, unprocessed 
pro-PrA-Ala2Y4 migrated as a somewhat smaller molec- 
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Fig. I. Immunoprecipitaticn of labeled PrA-antigen in cell extracts of 
wild-type strain YSl8 (PRAI). mutant strain YHH6S 
@wlAEN::HIS3) and SRI (prulAEN::HIS3. pDP53prc1l-Alrr”~). 
Cells were labeled at 30°C for 30 min with [“S]mcthionine. Extract 
mixtures containing90,uCi of radioactivity were applied on each lane. 
Chase time was 120 min. The chase solution contained 60j~gcyclohc- 
ximide/incubation mix. lmmunoprecipitation was done using anti- 
PrA-serum; SDS-PAGE (10% gel): (Lane I) YSl8. 120 min chase: 
(lane 2) YS18, pulse: (lane 3) SRI. pulse; (lane 4) SRI. 120 min chase; 
(lane 5) Y HH65. pulse: (lane 6) Y HH65. I20 min chase. 
ular weight species (51 kDa) than did the wild-type PrA 
precursor (52 kDa). Reasons for this shift in molecular 
weight might be: (i) altered trimming of the polysaccha- 
ride chains of the mutated protein; (ii) an altered pri- 
mary sequence due to limited proteolysis of pro-PrA- 
Ala?g$ or (iii) an altered mobility of the mutated pro- 
PrA-Ala?” protein in the SDS-PAGE due to the amino 
acid exchange. 
To evaluate the nature of this shift in molecular 
weight in more detail, we did the following experiments: 
(i) The molecular weight of the unglycosylated mu- 
tant PrA and its glycosylation pattern was determined. 
Radioactive labeling of cellular protein was done after 
incubation of mutant strain SRI (pralAEN::HIS3, 
pDPS3praI-Ah”‘) with tunicamycin. an inhibitor of N- 
acetylglucosaminyl-pyrophosphoryldolichol formation. 
As control wild-type YS18 (PRAI) and plasmid enco- 
ded wild-type SR2 (ptuIAEN:HIS3, pDP83PRAI) cells 
were treated in the same way. Since PrA contains two 
N-glycosylation sites, the occurrence of three different 
molecular species of PrA is expected if tunicamycin- 
repressed N-glycosylation is not complete [ 1 l] OS can bc 
seen in Fig. 2. PrA-Alazg’ of tunicamyr:in-tre~Ited cells 
Fig. 2. Glycosylation pattern of PrA-AlaX’. The yeast strains YSl8 
(PRAI). SRI (_muIAEN::HIS3. pDPSSpruI-Ah-‘“‘) and SR2 
@nr/AEN::HIS3.pDPSSPRAl) were prcincubated for 20 min at 30°C 
with 60 &ml tunicamycin prior to labeling with [‘“Slmethioninc for 
30 min. Extract mixtures containing 100 PCi of radioactivity wcrc 
applied on cacti lane. Immunoprecipitation was done using anti-PrA- 
strum: SDS-PAGE (12% gel): (Lane 1) SR2: (lane 2) YSl8: (lane 3) 
SRI. 
(Fig. 2. lane 3) showed the same glycosylation pattern 
as wild-type pro-PrA (Fig. 2. lane 2) but for each PrA- 
Ala”J species a smaller apparent molecular weight of 
about 1 kDa could be observed. Evidently a difference 
in molecular weight even between the completely ungly- 
cosylated wild-type and mutant species does exist. 
These observations show that altered trimming of poly- 
saccharide chains cannot account for the difference in 
molecular weight. 
To exclude (ii) we compared in vitro synthesized wild- 
type PrA and mutant PrA-Ala”’ proteins. Synthesis of 
both proteins was achieved by transcription-translation 
of the wild-type and mutant genes, PRAI and prol- 
AkivJ. cloned into the vector pGEM2. The mRNA of 
both genes was prepared by in vitro transcription with 
SP6 polymerase. Translation of the mRNA was done in 
the presence of [“‘Slmethionine in a wheat germ system 
(kindly provided by H.O. Krebs. [22]). Addition of the 
capped mRNAs to the translation reaction mixture re- 
sulted in a 44 kDa protein for the PRAI wild-type gene 
(Fig. 3. lane I), as expected for the unglycosylated full- 
length polypeptide chain [7.8]. and a 43 kDa protein for 
the~)~~~I-Aic~-‘~~ mutantgene (Fig. 3. lane 2). The molec- 
ular weights of wild-type PrA and mutant PrA-Alazq4 
show an apparent difference of about 1 kDa. (Several 
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Fig. 3. In vitro translation of wild-type PrA and PrA-Ala”“. For 
analysis of the [“S]methionine in vitro translation products of PRAl 
and pr~l-A/~?~ mRNA, 2 ~1 of mRNA were added to each translation 
mixture; SDS-PAGE (10% gel): (Lane 1) PRAI: (lane 2) prctl-Akf”‘. 
proteins of smaller molecular mass were also synthesi- 
Led in a pral-Ala”’ or PRAi mRNA dependent man- 
ner. They could be the result of non-standard usage of 
internal AUG codons at start of protein synthesis and/ 
or premature termination [32]. Thus the apparent shift 
in molecular weight of the mutant pro-PrA-Ala2y4 can- 
not be due to an altered length in the peptide chain of 
the protein. 
These experiments leave us only with possibility (iii), 
the altered mobility of mutant PrA-AlazV4 protein due 
to the exchange of the acidic amino acid aspartate 
against the neutral/hydrophobic amino acid alanine. 
Similar effects have been reported by Rosinski-Chupin 
et al. [33]. 
3.3. Tire mutant proreitl PrA-AlaZy is delivered to the 
vacuole 
The fact that PrA-AlaLy4 is sensitive to the N-glycosy- 
lation inhibitor tunicamycin (Fig. 2) indicates that the 
mutant protein travels through the secretory pathway 
[2]. Since neither the ER-directing pre-sequence nor the 
vacuole directing pro-sequence [9] of pre-pro-PrA have 
been changed by mutagenesis we expected that the PrA- 
Ala2y4 mutant protein is delivered to the vacuole. This 
was indeed the cast: the isolation of the vacuolar frac- 
tion from mutant strain SRI (~7rcrI&iV::HZS3, 
Fig. 4. lmmunoblotting of PrA antigenic material in spheroplasts and 
vacuoles of strain YHHBS (pm/dEN::HISjl) and strain SRI 
(pralAEN::HIS3. pDP83pt~~I-Alu-‘“). Each lane contained 5Opg total 
protein. Arrow marks PrA-Ala2YJ mutant protein; SDS-PAGE (10% 
gel): (Lane I) YHH65. sphcroplasts; (lane 2) YHH65, vacuoles; (lane 
3) SRI, vacuoles; (lane 4) SRI. spheroplasts: (lane 5) YSl8. crude 
extract. 
pDP83prai-Ala2v4) showed enrichment of PrA antigenic 
material (Fig. 4, lane 3). 
3.4. The pra 1 -Ala”‘j nwtation blocks maturation of pro- 
PrB and pro-Q Y 
Mature PrA has been shown to be the trigger for 
maturation of other vacuolar hydrolases [6-81. PrB and 
CpY are among the best examples studied [30,34-361. 
As can be seen in Fig. 5 presenting in vivo labeling 
experiments using [35S]metllionine, PrA-Alazy is unable 
to initiate maturation of the 42 kDa pro-PrB to the 
authentic mature 33 kDa PrB species (Fig. 5? lanes 5 and 
6). As control, wild-type strain YS18 (Fig. 5, lanes 1 and 
2) and strain SR2, chromosomally deleted in PrA but 
carrying a plasmid-encoded PrA wild-type gene (Fig. 5, 
lanes 3 and 4) both show maturation of PrB. Also im- 
munoblotting of vacuolar extracts of strain SRI car- 
rying the mutated pral-Ala’v4 allele showed only the 
presence of the unprocessed 42 kDa PrB precursor (not 
shown). As expected the loss of the PrA activity which 
prevents PrB maturation also abolishes processing of 
the 69 kDa CpY precursor to the authentic mature 61 
kDa CpY in the mutant strain SRI (prcrIAEN::HIS3, 
pDPS3proI-Ala2Y4) (not shown). 
This mutation of the amino acid ASPIRE seems to con- 
firm its predicted role as part of the catalytic site and 
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Fig. 5. Immunoprecipitation of labeled PrB-antigen in cell extracts of 
wild-type strain YS18 (PRAI) and mutant strains SR2 
@rulAEN::HIS3, pDP83PRAI) and SRI @ralAEN::HIS3, 
pDP83prd-Alp). Cells were labeled at 30°C for 30 min with 
[?S]methionine. Extract mixtures containing IOOpCi of radioactivity 
were applied on each lane. Chase time took 120 min. Immunoprecipi- 
tation was done using anti-P&serum; SDS-PAGE (10% gel): (Lane 
1) YS18. 120 min chase; (lane 2) YSl8. pulse; (lane 3) SR2, pulse; (lane 
4) SR2, 120 min chase; (lane 5) SRI, pulse: (lane 6) SRI. 120 min 
chase. 
results in complete deficiency of in vivo maturation of 
pro-PrA-Alazg4 itself and the 42 kDa precursor of PrB, 
as well as the 69 kDa precursor of CpY. 
4. DISCUSSION 
We have shown that exchange of Aspzg4 of yeast PrA 
against A1a2g4 (pral-Ah?‘*) by site directed mutagenesis 
destroys the in vitro activity of the enzyme and results 
in deficiency of processing of pro-PrA-Ala2g4 itself and 
two other vacuolar hydrolase precursors, the 42 kDa 
pro-PrB and the 69 kDa pro-CpY. Like wild-type PrA, 
the mutated PrA species (PrA-Ala2g4) travels through 
the secretory pathway to the vacuole (Figs. 2,4). Since 
the mutated protein [PrA-Ala’““) is located in the va- 
cuole the processing Deficiency of itself and of other 
vacuolar hydrolases due to mis-sorting effects can be 
excluded. The:e results are in agreement with the pre- 
diction that AspzgJ is one of the two catalytically active 
aspartate residues found in aspartate proteinases. An 
analogy to pepsinogen self-processing of pro-PrA has 
been proposed [7,8]. We could not observe any proces- 
sing of pro-PrA-Ala “’ to the 43 kDa or the 42 kDa form 
of the mature enzyme. Our results strongly indicate that 
processing of pro-Pr.4 is indeed autocatalytic in nature. 
However, we cannot completely exclude that the muta- 
tionp&-Al$g4 leads to an altered structure of the PrA- 
Ala2q4 mutant protein which cannot be processed by an 
as yet unknown proteinase. However, we consider this 
possibility rather unlikely since the mutant protein, like 
the wild-type protein, is correctly glycosylated and cor- 
rectly delivered to the vacuole. 
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